Denmark Warns DTP Vaccine Increases Child Mortality Rate Tenfold

Denmark Warns DTP Vaccine Increases Child Mortality Rate Tenfold

A Danish scientific study warns that children vaccinated with the DTP vaccine may face a mortality rate up to ten times higher than their unvaccinated peers. 

While the CDC and the World Health Organization refuse to perform vaccine safety studies or publish reports on vaccinated vs. unvaccinated children, the data from the Danish government study lends further weight to the argument that the public have a right to know more about vaccine safety.

The rare study, funded in part by the Danish government and led by Dr. Soren Wengel Mogensen, was published in January in EBioMedicine.

Dr. Mogensen and his team of scientists found that African children inoculated with the DTP (diphtheria, tetanus and pertussis) vaccine had a 5-10 times greater mortality rate than their unvaccinated peers.

The data suggests that, while the vaccine may protect against infection from those three bacteria, it significantly weakens the immune system and damages overall health, making children more susceptible to dying from other causes.

Worldmercuryproject.org reports: The scientists term the study a “natural experiment” since a birthday-based vaccination system employed for the Bandim Health Project (BHP) in Guinea Bissau, West Africa had the effect of creating a vaccinated cohort and a similarly situated unvaccinated control group.

In the time period covered by this study, Guinea-Bissau had 50% child mortality rates for children up to age 5. Starting in 1978, BHP health care workers contacted pregnant mothers and encouraged them to visit infant weighing sessions provided by a BHP team every three months after their child’s birth.

Beginning in 1981, BHP offered vaccinations at the weighing sessions.  Since the DPT vaccine and OPV (oral polio) immunizations were offered only to children who were at least three months of age at the weighing sessions, the children’s random birthdays allowed for analysis of deaths between 3 and 5 months of age depending on vaccination status.

So, for example, a child born on January 1st and weighed on April 1st would be vaccinated, but a child born on February 1st would not be vaccinated until their following visit at age 5 months on July 1st.

In the primary analysis, DTP-vaccinated infants experienced mortalities five times greater than DTP-unvaccinated infants.

Mortalities to vaccinated girls were 9.98 times those among females in the unvaccinated control group, while mortalities to vaccinated boys were 3.93 times the controls.

Oddly, the scientists found that children receiving the oral polio vaccine simultaneously with DTP fared much better than children who did not.  The OPV vaccine appeared to modify the negative effect of the DTP vaccine, reducing mortalities to 3.52 times those experienced among the control group.

Overall, mortalities among vaccinated children were 10 times the control group when children received only the DTP.

Mogensen and his colleagues hypothesize that the DTP vaccine might weaken a child’s immune system against non-target infections.

They conclude, “Though protective against the target disease, DTP may increase susceptibility to unrelated infections… DTP was associated with 5-fold higher mortality than being unvaccinated.  No prospective study has shown beneficial survival effects of DTP.”

The Mogensen study supports the conclusions of previous investigations into child survival following vaccination.  An earlier study by Dr. Peter Aaby, of the introduction of DTP in rural Guinea-Bissau, indicated a 2-fold higher mortality among vaccinated children (Aaby et al. 2004a).  The Aaby report is one of several early studies that documented vaccination status and followed children prospectively.

All of them indicated that DTP-vaccinated children died at rates far exceeding mortality amongst the control group.  A meta-analysis of all eight known studies found a two-fold higher mortality for DTP-vaccinated compared to DTP-unvaccinated (Aaby et al. 2016) (Appendix A).

In 2014, The World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) conducted its own literature review of the potential non-specific effects (NSEs) of several vaccines, including DTP, and found that the majority of studies reported a detrimental effect of DTP (Higgins et al., 2014; Strategic Advisory Group of Experts of Immunization, 2014) due to its penchant for increasing susceptibility to unrelated infections.  SAGE recommended further research.

Moreover, Mogensen and his colleagues observe that the studies reviewed by SAGE probably underestimated the lethal effect of the DTP vaccine because of unusually high mortality in the control groups, ”Unvaccinated children in these studies have usually been frail children too sick or malnourished to get vaccinated and the studies may therefore have underestimated the negative effect of DTP”.

The Mogensen study sought to avoid this pitfall by using controls selected by birthday and by eliminating underweight children and orphans from both the study group and the control group.

It included only children who were breastfed.  All the infants were healthy at the time of vaccination.  Nevertheless, the Mogensen authors point out that, even in their study, the unvaccinated children had slightly worse nutritional status and travelled more – biases that would tend to increase mortality.

They conclude that, “The estimate from the natural experiment may therefore still be conservative.”

The significance of the Mogensen study findings is underscored by the observation that, “Unfortunately, DTP is the most widely used vaccine, and the proportion who receives DTP3 is used globally as an indicator of the performance of national vaccination programs.”

The authors close with a bracing rebuke to public health regulators, “It should be of concern that the effect of routine vaccinations on all-cause mortality was not tested in randomized trials.  All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis.  Though a vaccine protects children against the target disease it may simultaneously increase susceptibility to unrelated infections.”

Those words should serve as a cold water wake-up call to the World Health Organization (WHO), the CDC and other public health officials.

The public in both poor and rich countries has a right to scientifically-based evidence that international vaccine programs are as safe as possible and that they have been thoroughly safety-tested.  The best metrics for measuring safety are studies comparing health outcomes of vaccinated versus unvaccinated cohorts.  Yet, both the CDC and the WHO have aggressively discouraged the pursuit of such studies.

Finally, it’s important to note that the DTP vaccine used in Guinea-Bissau in the early 1980s almost certainly contained high concentrations of both mercury and aluminum. Vaccine makers first created the combined diphtheria, tetanus and pertussis vaccine in the 1940s, mixing in an aluminum adjuvant and a mercury preservative (thimerosal) from its inception.  At that time, the American Academy of Pediatrics recommended DTP for mass use in children. Prior to 1990, DTP was the only thimerosal-containing vaccine recommended for infants.

Five manufacturers supplied UNICEF with the DTP vaccines used in West Africa in the late 1970s and early 1980s.  One of these, Biken of Japan, described the industry standard in its 1987 lab report: “Outline of Method of Manufacture—The preparation [of DTP] also contains thimerosal as a preservative.”

By the early 1980s, a cascade of lawsuits filed across the United States on behalf of vaccine-injured children were driving DTP manufacturers from the market and threatening to shut down production of the DTP shot and other vaccines.

That threat led the U.S. Congress to bestow legal immunity on vaccine makers via the National Childhood Vaccine Injury Program in 1986, followed in December, 1987, by the rollout of “Vaccine Court.”

Following the recommendation by the Institute of Medicine, vaccine makers removed thimerosal from the American DTaP between 2001-2003.  However, multi-dose DTP vaccines given to tens of millions of children across the African continent continue to contain massive doses of thimerosal (25mcg of ethylmercury per injection) that exceed the EPA’s maximum exposure levels by many times.

Neither the CDC nor the WHO has ever published a vaccinated vs. unvaccinated study that would be necessary to determine the overall health impacts of this potent toxin on African children.

The Mogensen report is a loud call for such a study.

  • i Witness NEWS
    • 7 views
    By i Witness NEWS

    Johns Hopkins Scientist Reveals Shocking Report on Flu Vaccines

    A Johns Hopkins scientist has issued a blistering report on influenza vaccines in the British Medical Journal (BMJ). Peter Doshi, Ph.D., charges that although the vaccines are being pushed on the public in unprecedented numbers, they are less effective and cause more side effects than alleged by the Centers for Disease Control and Prevention (CDC). Further, says Doshi, the studies that underlie the CDC’s policy of encouraging most people to get a yearly flu shot are often low quality studies that do not substantiate the official claims.

     

    Promoting influenza vaccines is one of the most visible and aggressive public health policies in the United States, says Doshi of the Johns Hopkins School of Medicine. Drug companies and public officials press for widespread vaccination each fall, offering vaccinations in drugstores and supermarkets. The results have been phenomenal. Only 20 years ago, 32 million doses of influenza vaccine were available in the United States on an annual basis. Today, the total has skyrocketed to 135 million doses.
     

     

    “The vaccine may be less beneficial and less safe than has been claimed, and the threat of influenza seems to be overstated,” Doshi says. Mandatory vaccination polices have been enacted, often in healthcare facilities, forcing some people to take the vaccine under threat of losing their jobs.

     

    The main assertion of the CDC that fuels the push for flu vaccines each year is that influenza comes with a risk of serious complications which can cause death, especially in senior citizens and those suffering from chronic illnesses. That’s not the case, said Doshi.
     

    When read carefully, the CDC acknowledges that studies finding any perceived reduction in death rates may be due to the “healthy-user effect” — the tendency for healthier people to be vaccinated more than less-healthy people. The only randomized trial of influenza vaccine in older people found no decrease in deaths. “This means that influenza vaccines are approved for use in older people despite any clinical trials demonstrating a reduction in serious outcomes,” says Doshi.

     

    Even when the vaccine is closely matched to the type of influenza that’s prevalent, which doesn’t happen every year, randomized, controlled trials of healthy adults found that vaccinating between 33 and 100 people resulted in one less case of influenza. In addition, says Doshi, no evidence exists to show that this reduction in the risk of influenza for a specific population — here in the United States, among healthy adults, for example — extrapolates into any reduced risk of serious complications from influenza, such as hospitalizations or deaths, among seniors.

     

    “For most people, and possibly most doctors, officials need only claim that vaccines save lives, and it is assumed there must be solid research behind it,” says Doshi. Unfortunately, that’s not the case, he says.
     

     

    Although the CDC  implies that flu vaccines are safe and there’s no need to weigh benefits against risk, Doshi disagrees. He points to an Australian study that found one in every 110 children under the age of five had convulsions following vaccinations in 2009 for H1N1 influenza. Additional investigations found that the H1N1 vaccine was also associated with a spike in cases of narcolepsy among adolescents.

     

    Doshi’s concerns echo those of Dr. Russell Blaylock, a neurosurgeon and author of “The Blaylock Wellness Report” who has deep concerns over the safety and efficacy of the flu vaccine.
     
    Not only is the vaccine not safe, Dr. Blaylock tells Newsmax Health, it doesn’t even work. “The vaccine is completely worthless, and the government knows it,” he says. “There are three reasons the government tells the elderly why they should get flu shots: secondary pneumonia, hospitalization, and death. Yet a study by the Cochrane group studied hundreds of thousands of people and found it offered zero protection for those three things in the general community. It offered people in nursing homes some immunity against the flu — at best one-third — but that was only if they picked the right vaccine.”

     

    A study released in February found that the flu shot was only 9 percent effective in protecting seniors against the 2012-2013 season’s most virulent influenza bug.

     

    What’s even worse is that small children who are given the flu vaccine get no protection from the disease. “The government also says that every baby over the age of six months should have a vaccine, and they know it contains a dose of mercury that is toxic to the brain,” says Dr. Blaylock. “They also know the studies have shown that the flu vaccine has zero — zero — effectiveness in children under five.”

     

    For most people, says Dr. Blaylock, flu vaccines don’t prevent the flu but actually increase the odds of getting it. The mercury contained in vaccines is such a strong immune depressant that a flu shot suppresses immunity for several weeks. “This makes people highly susceptible to catching the flu,” he says. “They may even think the vaccine gave them the flu, but that’s not true — it depressed their immune system and then they caught the flu.”

     

    Mercury overstimulates the brain for several years, says Dr. Blaylock, and that activation is the cause of Alzheimer’s and other degenerative diseases. One study found that those who get the flu vaccine for three to five years increase their risk of Alzheimer’s disease 10-fold.

     

    Doshi asserts that influenza is a case of “disease mongering” in an effort to expand markets. He points to the fact that deaths from flu declined sharply during the middle of the 20th century, long before the huge vaccine campaigns that kicked off the 21st century.
     
    Why do drug companies push the flu vaccine? “It’s all about money,” says Dr. Blaylock. “Vaccines are a pharmaceutical company’s dream. They have a product that both the government and the media will help them sell, and since vaccines are protected, they can’t be sued if anyone has a complication.”

     

    Doshi’s article “is a breath of fresh air,” says Dr. Blaylock. “This article exposes in well-defined and articulate terms what has been known for a long time — the flu vaccine promotion is a fraud.

     

    “Here’s the bottom line,” says Dr. Blaylock. “The vast number of people who get the flu vaccine aren’t going to get any benefit, but they get all of the risks and complications.”

     

     
Videos on SpiritualFamily.Net Youtube Logo
Search Videos:

Results (max 10):



Perfect Health & Well Being

Perfect Health & Well Being

It is to the mind of perfect poise, housed in a body of clean habits, stabilized neural energies, and balanced chemical function — when the physical, mental, and spiritual powers are in triune harmony of development — that a maximum of light and truth can be imparted with a minimum of temporal danger or risk to the real welfare of such a being.